top of page

ARJIL

One Arjil product a day,keeps the Day great

Only through Arjil, better life could be true

aboutus

Company profiles

ARJIL Pharmaceuticals LLC, founded in 2014, is a development stage specialty pharmaceutical company which focused on advancing and commercializing innovative medical products. Since its inception, Arjil are committed to the ongoing discovery, development and delivery of botanical basis medicines for elderly globally.

The contributed capital of Arjil in 2020 is up to 108.9 M. 

吳郁彬董事長.jpg.png

Yeh B, Wu MD.

Chairman of the board

New York University Bellevue Hospital , NY
Setup anesthesia and pain clinic, NJ
Investment in Arch Venture Fund, Chicago 
Zeitech Corp Chairman, NJ
TBS Pharmaceutical Company Board of Directors,NJ
Barjil Investment Group Chairman, NJ

Our Team

圖片8.jpg
趙麗玲.png
圖片9.png

Biomedical Technology and Device

Research Laboratories, ITRI
Natural product isolation 
NTOU, Master

Hui-Ju Liang
Product Manager

Dr. Li-Ling Chao 
Chief Financial Officer

Postdoc. National Changhua University of Education
Green Flatek, INC. manager
Tunghai University; Adjunct Assistant Professor

Postdoc. National Chung Hsing University

PhD, Biotechnology, NCHU

Dr. Ming-Kun Chen

Manager

Richard Wu.jpg
dr jane sc tsai.png

Richard Wu, MD

medical adviser

Dr. Jane SC Tsai

Honorary Consultant U.S.A.

Emergency Care and Thoracic Specialty

Columbia University
 

SVP(Senior Vice President)

 International Affairs, 
YFY Biotech Management Company
Senior Advisor,

Former Deputy General Director and COO(Chief Operating Officer),

CTO(Chief Technology Officer),

ITRI 
Roche Former Director,

Services
Web Consultation

Our services

We are committed to developing medicines for unmet medical needs and improving quality life products, including bioactive botanical cosmetic ingredients, healthy foods derived from botanical drugs, and anti-aging products for improving and extending quality of life for elderly people. 

Hearing Aid

Our strength

With the QMS (Quality Management System) having been established on our organization infrastructure along the IND process, we have been holistically approaching and accelerating our drug R&D in data driven & risk managed (assessed) manners, and consistently moving toward a successful track in a predictable way.

Contact information

Rm.205, Center of Innovative Incubator, 101, Sec.2, Kuang-Fu Road, Hsinchu 30013, Taiwan

Business:

+8863-5733608

Primary Contact:

Ming-Kun Chen/mkchen@arjilbio.com

Strength
Contact Information
bottom of page